SCHEMBL4443074

SCHEMBL4443074

C[C@](O)(CNC1CCN(Cc2ccc(Cl)cc2)CC1)COc1cc(O)c(Cl)cc1CC(N)=O

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.62
ABCB11 O95342 2/20 0.60
CCR5 P51681 3/20 0.41
SIGMAR1 Q99720 4/20 0.41
SSTR1 P30872 1/20 0.38
SSTR4 P31391 1/20 0.38
TEAD1 P28347 1/20 0.38
BCHE P06276 2/20 0.38
ACHE P22303 2/20 0.38
BACE1 P56817 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MCHR1 Q99705 2/20 0.38
SLC6A12 P48065 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4440496 0.97 CCR1 (0.59) CCR1ABCB11CCR5SIGMAR1SSTR1
SCHEMBL30172128 0.85 CCR1 (0.60) CCR1ABCB11CCR5SIGMAR1TEAD1
SCHEMBL1950538 0.84 CCR1 (0.80) CCR1ABCB11CCR5SIGMAR1TEAD1
SCHEMBL3140501 0.84 ABCB11 (0.65) CCR1ABCB11CCR5SIGMAR1BCHE
SCHEMBL3675985 0.83 CCR1 (0.68) CCR1ABCB11CCR5SIGMAR1TEAD1
SCHEMBL3154883 0.82 ABCB11 (0.65) CCR1ABCB11CCR5SIGMAR1TEAD1
Sulfuric Acid SCHEMBL1952168 0.82 CCR1 (0.76) CCR1ABCB11CCR5SIGMAR1TEAD1
SCHEMBL3682423 0.81 ABCB11 (0.56) CCR1ABCB11BCHEACHEMCHR1
SCHEMBL3135724 0.80 ABCB11 (0.72) CCR1ABCB11CCR5SIGMAR1SSTR1
Trifluoroacetic Acid SCHEMBL3149939 0.80 ABCB11 (0.60) CCR1ABCB11CCR5SIGMAR1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4115885-A1 A PHARMACEUTICAL COMPOSITION COMPRISING BAY 86-5277 AND SALTS THEREOF FOR USE IN THE TREATMENT OF VIRAL INFECTIONS AND HYPERINFLAMMATION Charité - Universitätsmedizin Berlin (DE) 2023-01-11 EP disclosed
EP-2125728-A1 NOVEL COMBINATION OF COMPOUNDS TO BE USED IN THE TREATMENT OF AIRWAY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA AstraZeneca AB (SE) 2009-12-02 EP disclosed
WO-2008103125-A1 NOVEL COMBINATION OF COMPOUNDS TO BE USED IN THE TREATMENT OF AIRWAY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA ASTRAZENECA AB (SE) 2008-08-28 WO disclosed